Clinton Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-69,453
| Closed | -$2.53M | – | 431 |
|
|
2017
Q3 | $2.53M | Buy |
69,453
+12,915
| +23% | +$471K | 0.28% | 113 |
|
|
2017
Q2 | $2.23M | Buy |
56,538
+7,833
| +16% | +$309K | 0.23% | 141 |
|
|
2017
Q1 | $1.53M | Sell |
48,705
-25,224
| -34% | -$791K | 0.09% | 318 |
|
|
2016
Q4 | $2.31M | Buy |
+73,929
| New | +$2.31M | 0.13% | 217 |
|
|
2016
Q3 | – | Sell |
-119,388
| Closed | -$3.97M | – | 950 |
|
|
2016
Q2 | $3.97M | Buy |
119,388
+91,608
| +330% | +$3.05M | 0.17% | 164 |
|
|
2016
Q1 | $817K | Sell |
27,780
-102,645
| -79% | -$3.02M | 0.05% | 475 |
|
|
2015
Q4 | $3.43M | Buy |
+130,425
| New | +$3.43M | 0.28% | 101 |
|
|
2015
Q3 | – | Sell |
-12,618
| Closed | -$300K | – | 717 |
|
|
2015
Q2 | $300K | Buy |
+12,618
| New | +$300K | 0.04% | 472 |
|
|
2014
Q4 | – | Sell |
-27,030
| Closed | -$460K | – | 497 |
|
|
2014
Q3 | $460K | Buy |
+27,030
| New | +$460K | 0.19% | 192 |
|
|
2013
Q4 | – | Sell |
-71,922
| Closed | -$835K | – | 337 |
|
|
2013
Q3 | $835K | Buy |
+71,922
| New | +$835K | 0.25% | 83 |
|